Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Rowart, Pascal ^a   Erpicum, Pauline ^a   Detry, Olivier ^a   Weekers, Laurent ^a   Grégoire, Céline ^a   Lechanteur, Chantal ^a   Briquet, Alexandra ^a   Beguin, Yves ^a   Krzesinski, Jean Marie ^a   Jouret, François ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ISCHEMIA; CELL THERAPY; CLINICAL TRIAL (TOPIC); HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY ISCHEMIA; LIVER ISCHEMIA; MESENCHYMAL STROMA CELL; MESENCHYMAL STROMA CELL THERAPY; NONHUMAN; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; SOLID ORGAN TRANSPLANTATION; TISSUE REPAIR; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; KIDNEY DISEASES; LIVER DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHENOTYPE;

MEMBRANE ANTIGEN;

ANIMALS; ANTIGENS, SURFACE; BRAIN ISCHEMIA; CELL- AND TISSUE-BASED THERAPY; HUMANS; KIDNEY DISEASES; LIVER DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL REPERFUSION INJURY; PHENOTYPE; REPERFUSION INJURY;

EID: 84938258343     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/602597     Document Type: Review

References (60)

1. H. K. Eltzschig and C. D. Collard, "Vascular ischaemia and reperfusion injury, " British Medical Bulletin, vol. 70, pp. 71-86, 2004.
2. C. E. Ponticelli, "The impact of cold ischemia time on renal transplant outcome, " Kidney International, vol. 87, no. 2, pp. 272-275, 2015.
3. A. I. Caplan, "Mesenchymal stem cells, " Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641-650, 1991.
4. P. Erpicum, O. Detry, L. Weekers, C. Bonvoisin, C. Lechanteur, and A. Briquet, "Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion, " Nephrology Dialysis Transplantation, vol. 29, pp. 1487-1493, 2014.
5. M. A. Puglisi, V. Tesori, W. Lattanzi et al. , "Therapeutic implications ofmesenchymal stem cells in liver injury, " Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 860578, 8 pages, 2011.
6. A. J. Nauta, A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe, "Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells, " Journal of Immunology, vol. 177, no. 4, pp. 2080-2087, 2006.
7. X. C. Li and L. A. Turka, "An update on regulatory T cells in transplant tolerance and rejection, " Nature Reviews Nephrology, vol. 6, no. 10, pp. 577-583, 2010.
8. Z. Selmani, A. Naji, I. Zidi et al. , "Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte andnatural killer functionand to induce CD4+ CD25highFOXP3+ regulatory T cells, " StemCells, vol. 26, no. 1, pp. 212-222, 2008.
9. S. Bruno, C. Grange, F. Collino et al. , "Microvesicles derived frommesenchymal stem cells enhance survival in a lethalmodel of acute kidney injury, " PLoSONE, vol. 7, no. 3, Article IDe33115, 2012.
10. M. N. Islam, S. R. Das, M. T. Emin et al. , "Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury, " Nature Medicine, vol. 18, no. 5, pp. 759-765, 2012.
11. L. Biancone, S. Bruno, M. C. Deregibus, C. Tetta, and G. Camussi, "Therapeutic potential of mesenchymal stem cellderived microvesicles, " Nephrology Dialysis Transplantation, vol. 27, no. 8, pp. 3037-3042, 2012.
12. F. Carríon, E. Nova, P. Luz, F. Apablaza, and F. Figueroa, "Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation, " Immunology Letters, vol. 135, no. 1-2, pp. 10-16, 2011.
13. Z. Jia, C. Jiao, S. Zhao et al. , "Immunomodulatory effects ofmesenchymal stem cells in a rat corneal allograft rejection model, " Experimental Eye Research, vol. 102, pp. 44-49, 2012.
14. T. Ben-Mordechai, R. Holbova, N. Landa-Rouben et al. , "Macrophage subpopulations are essential for infarct repair with and without stem cell therapy, " Journal of the American College of Cardiology, vol. 62, no. 20, pp. 1890-1901, 2013.
15. J. Kim and P. Hematti, "Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages, " ExperimentalHematology, vol. 37, no. 12, pp. 1445-1453, 2009.
16. J. Maggini, G. Mirkin, I. Bognanni et al. , "Mouse bone marrowderivedmesenchymal stromal cells turn activatedmacrophages into a regulatory-like profile, " PLoS ONE, vol. 5, no. 2, Article ID e9252, 2010.
17. Z.-G. Zhao, W. Xu, L. Sun et al. , "Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells, " Immunological Investigations, vol. 41, no. 2, pp. 183-198, 2012.
18. N. Souidi, M. Stolk, and M. Seifert, "Ischemia-reperfusion injury: beneficial effects of mesenchymal stromal cells, " Current Opinion in Organ Transplantation, vol. 18, no. 1, pp. 34-43, 2013.
19. F. E. Tögel andC. Westenfelder, "Mesenchymal stem cells: a new therapeutic tool for AKI, " Nature Reviews Nephrology, vol. 6, no. 3, pp. 179-183, 2010.
20. A. I. Caplan and J. E. Dennis, "Mesenchymal stem cells as trophic mediators, " Journal of Cellular Biochemistry, vol. 98, no. 5, pp. 1076-1084, 2006.
21. G. Camussi, M. C. Deregibus, S. Bruno, V. Cantaluppi, and L. Biancone, "Exosomes/microvesicles as a mechanism of cell-tocell communication, " Kidney International, vol. 78, no. 9, pp. 838-848, 2010.
22. D. L. Carden and D. N. Granger, "Pathophysiology of ischaemia-reperfusion injury, " Journal of Pathology, vol. 190, no. 3, pp. 255-266, 2000.
23. M. Kosieradzki andW. Rowínski, "Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention, " Transplantation Proceedings, vol. 40, no. 10, pp. 3279-3288, 2008.
24. C. Li and R. M. Jackson, "Reactive species mechanisms of cellular hypoxia-reoxygenation injury, " The American Journal of Physiology-Cell Physiology, vol. 282, no. 2, pp. C227-C241, 2002.
25. K. Raedschelders, D. M. Ansley, and D. D. Y. Chen, "The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion, " Pharmacology andTherapeutics, vol. 133, no. 2, pp. 230-255, 2012.
26. L. Weekers, P. de Tullio, C. Bovy et al. , "Activation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury, " American Journal of Translational Research, vol. 7, pp. 128-138, 2015.
27. C. Y. Lu, Seldin and Giebisch'sThe Kidney, Elsevier, 2013.
28. D. Bon, N. Chatauret, S. Giraud, R. Thuillier, F. Favreau, and T. Hauet, "New strategies to optimize kidney recovery and preservation in transplantation, " Nature Reviews Nephrology, vol. 8, no. 6, pp. 339-347, 2012.
29. A. Ioannou, J. D. Lucca, and G. C. Tsokos, "Immunopathogenesis of ischemia/reperfusion-associated tissue damage, " Clinical Immunology, vol. 141, no. 1, pp. 3-14, 2011.
30. R. Fuquay, B. Renner, L. Kulik et al. , "Renal ischemia-reperfusion injury amplifies the humoral immune response, " Journal of the American Society of Nephrology, vol. 24, no. 7, pp. 1063-1072, 2013.
31. B. Renner, D. Strassheim, C. R. Amura et al. , "B cell subsets contribute to renal injury and renal protection after ischemia/ reperfusion, " The Journal of Immunology, vol. 185, no. 7, pp. 4393-4400, 2010.
32. L. Zhang, F. Jouret, J. Rinehart et al. , "AMP-activated protein kinase (AMPK) activation and glycogen synthase kinase-3(GSK-3) inhibition induce Ca2+-independent deposition of tight junction components at the plasma membrane, " The Journal of Biological Chemistry, vol. 286, no. 19, pp. 16879-16890, 2011.
33. F. Tögel, Z. Hu, K. Weiss, J. Isaac, C. Lange, and C. Westenfelder, "Administered mesenchymal stemcells protect against ischemic acute renal failure through differentiation-independentmechanisms, " The American Journal of Physiology-Renal Physiology, vol. 289, no. 1, pp. F31-F42, 2005.
34. S. Kale, A. Karihaloo, P. R. Clark, M. Kashgarian, D. S. Krause, and L. G. Cantley, "Bonemarrowstemcells contribute to repair of the ischemically injured renal tubule, " Journal of Clinical Investigation, vol. 112, no. 1, pp. 42-49, 2003.
35. M. Gregorini, F. Bosio, C. Rocca et al. , "Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation, " BMC Immunology, vol. 15, no. 1, p. 44, 2014.
36. C. Akyurekli, Y. Le, R. B. Richardson, D. Fergusson, J. Tay, and D. S. Allan, "A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles, " Stem Cell Reviews and Reports, vol. 11, no. 1, pp. 150-160, 2015.
37. S. Bruno, C. Grange, M. C. Deregibus et al. , "Mesenchymal stem cell-derived microvesicles protect against acute tubular injury, " Journal of theAmerican Society of Nephrology, vol. 20, no. 5, pp. 1053-1067, 2009.
38. X. Xu, A. J. Kriegel, Y. Liu et al. , "Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21, " Kidney International, vol. 82, no. 11, pp. 1167-1175, 2012.
39. K. Bhatt, L. Zhou, Q.-S. Mi, S. Huang, J.-X. She, and Z. Dong, "MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival, " Molecular Medicine, vol. 16, no. 9-10, pp. 409-416, 2010.
40. H.-Y. Zhu, M.-Y. Liu, Q. Hong et al. , "Role of microRNA-181a in the apoptosis of tubular epithelial cell induced by cisplatin, " Chinese Medical Journal, vol. 125, no. 3, pp. 523-526, 2012.
41. S. V. Fleig and B. D. Humphreys, "Rationale of mesenchymal stem cell therapy in kidney injury, " Nephron Clinical Practice, vol. 127, pp. 75-80, 2014.
42. J. Tan, W. Wu, X. Xu et al. , "Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial, " The Journal of the American Medical Association, vol. 307, no. 11, pp. 1169-1177, 2012.
43. T. K. Kuo, S.-P. Hung, C.-H. Chuang et al. , "Stemcell therapy for liver disease: parameters governing the success of using bone marrowmesenchymal stem cells, " Gastroenterology, vol. 134, no. 7, pp. 2111. e3-2121. e3, 2008.
44. R. F. Saidi, B. Rajeshkumar, A. Shariftabrizi et al. , "Human adipose-derived mesenchymal stem cells attenuate liver ischemia-reperfusion injury and promote liver regeneration, " Surgery, vol. 156, no. 5, pp. 1225-1231, 2014.
45. M.-E. M. Amer, S. Z. El-Sayed, W. A. El-Kheir et al. , "Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells, " European Journal of Gastroenterology & Hepatology, vol. 23, no. 10, pp. 936-941, 2011.
46. O. Detry, M.-H. Delbouille, C. Lechanteur et al. , "Infusion of third-party mesenchymal stem cells after liver transplantation: a phase-1, open-label, clinical study, " Acta Gastro-Enterologica Belgica, vol. 78, 2015.
47. S. Van Linthout, C. Stamm, H.-P. Schultheiss, and C. Tschöpe, "Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond, " Cardiology Research and Practice, vol. 2011, Article ID 757154, 8 pages, 2011.
48. D. Angoulvant, F. Ivanes, R. Ferrera, P. G. Matthews, S. Nataf, and M. Ovize, "Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury, " Journal of Heart and Lung Transplantation, vol. 30, no. 1, pp. 95-102, 2011.
49. S. Bian, L. Zhang, L. Duan, X. Wang, Y. Min, and H. Yu, "Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model, " Journal of Molecular Medicine, vol. 92, no. 4, pp. 387-397, 2014.
50. Y. Cheng, N. Tan, J. Yang et al. , "A translational study of circulating cell-free microRNA-1 in acute myocardial infarction, " Clinical Science, vol. 119, no. 2, pp. 87-95, 2010.
51. Y. Tang, Y. Wang, K. M. Park et al. , "MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death, " Cardiovascular Research, vol. 106, no. 3, pp. 387-397, 2015.
52. A. W. Heldman, D. L. DiFede, J. E. Fishman et al. , "Transendocardialmesenchymal stem cells and mononuclear bonemarrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial, " The Journal of the American Medical Association, vol. 311, no. 1, pp. 62-73, 2014.
53. S. Law and S. Chaudhuri, "Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges, " American Journal of Stem Cells, vol. 2, no. 1, pp. 22-38, 2013.
54. Y. Li, M. Chopp, J. Chen et al. , "Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice, " Journal of Cerebral Blood Flow and Metabolism, vol. 20, no. 9, pp. 1311-1319, 2000.
55. T. M. Bliss, R. H. Andres, and G. K. Steinberg, "Optimizing the success of cell transplantation therapy for stroke, " Neurobiology of Disease, vol. 37, no. 2, pp. 275-283, 2010.
56. J. Zhang, Y. Li, J. Chen et al. , "Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells, " Brain Research, vol. 1030, no. 1, pp. 19-27, 2004.
57. H. Kanazawa, Y. Fujimoto, T. Teratani et al. , "Bone marrowderived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model, " PLoS ONE, vol. 6, no. 4, Article ID e19195, 2011.
58. N. Liu, R. Chen, H. Du, J. Wang, Y. Zhang, and J. Wen, "Expression of IL-10 and TNF in rats with cerebral infarction after transplantationwithmesenchymal stem cells, "Cellular and Molecular Immunology, vol. 6, no. 3, pp. 207-213, 2009.
59. M.-J. Tsai, S.-K. Tsai, B.-R. Hu et al. , "Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats, " Journal of Biomedical Science, vol. 21, no. 1, article 5, 2014.
60. M.-G. Lagny, F. Jouret, J.-N. Koch et al. , "Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification, " BMC Nephrology, vol. 16, article 76, 2015.